1Mancia G,Laurent S,Agabiti-Rosei E,et al.Reappraisal of European guidelines on hypertension management:a European Society of Hypertension Task Force document[J].J Hypertens,2009,27(11):2121-2158.
2Cameron JD,Mc Grath BP,Dart AM.Use of radial artery app lanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension[J].J Am Coll Cardiol,1998,32(5):1214-1220.
3Op Rourke MF,Pauca AL.Augmentation of the aortic and central arterial pressure waveform[J].Blood Press Monit,2004,9(1):179-185.
4Williams B,Lacy PS,Thom SM,et al.Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes:principal results of the Conduit Artery Function Evaluation(CAFE) study[J].Circulation,2006,113(9):1213-1225.
5Ueda H,Hayashi T,Tsumura K,et al.The timing of the reflected wave in the ascending aortic pressure predicts restenosis after coronary stent p lacement[J].Hypertens Res,2004,27(8):535-540.
6Lurbe E,Torro MI,Carvajal E,et al.Birth weight impacts on wave reflections in children and adolescents[J].Hypertension,2003,41(3):646-650.
7Morgan T,Lauri J,Bertram D,et al.Effect of different antihypertensive drug classes on central aortic pressure[J].Am J Hypertens,2004,17(2):118-123.
8Kingwell BA,Waddell TK,Medley TL,et al.Large artery stiffness predicts ischemic threshold in patients with coronary artery disease[J].J Am Coll Cardiol,2002,40(4):773-779.
9Chirinos JA,Zambrano JP,Chakko S,et al.Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease[J].Hypertension,2005,45(5):980-985.
2Boutouyrie P,Tropeano AI,Asmar R,et al.Aortic stiffness is an independent predictor of primary events in hypertensive patients:a longitudinal study[J].Hypertension,2002,39(1):10-15.
3Matsui Y,Kario K,Ishikawa J,et al.Reproducibility of arterial stiffness indices (Pulse Ware Velocity and Augmentation Index) simultaneously assessed by automated pulse wave analysis and their associated risk in essential hypertensive patients[J].Hypertens Res,2004,27 (11):851-857.
5Ballantyne C M,Pazzucconi F,Pint6 X,et al.Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis[J].Clin Ther,2001,23 (2):177- 192.
6O'Rourke M F. Wave travel and reflection in the arterial system[J ].J Hypertens,1999,17 (5) :$45-$47.
7Neuvonen P J. Drug interactions with HMG-CoA redu-ctase inhibitors (statins):the importance of CYP enzy- mes, transporters and pharmacogenetics [J ].Curr Opin Investig Drugs,2010,11 (3):323-332.
8Ballantyne C M,Pazzucconi F,Pint6 X,et al. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis[J].Clin Ther,2001,23(2):177- 192.
